Assessing logistical and ethical barriers for psychedelic-assisted therapy implementation: A cross-sectional pharmacist survey
Psychedelics April 20, 2026 Sophia M. Castillo, Noelle Cataldo, Cody J. Wenthur
Despite the existence of current treatments for major depressive disorder (MDD), depression symptoms and burdens often persist, prompting the need for novel therapies, including psychedelic-assisted therapy (PAT), with promising potential for early and durable antidepressant responses. Objectives: This research aims to compare pharmacist opinions regarding logistical and ethical considerations...